Investing in tomorrow's healthcare
We create and manage investment funds dedicated to innovative healthcare companies in Europe — from scientific discovery to tomorrow's treatments.
Our Mission
We have high standards
We have built a strong network of partners with the best European academic research players, to transform their disruptive scientific discoveries into cutting-edge medicines or medical devices to diagnose and treat patients with severe diseases with high unmet medical need.
We build companies
Our ambition is to work with leading European research centers to build the healthcare industry of tomorrow.
In that perspective, we have developed a unique approach. We work closely with the research teams early on to define a plan to validate their discoveries and bring together the best healthcare industry experts and later the most experienced entrepreneurs to create high-tech companies.
We provide capital/funding to the companies we have founded with our funds and invite other investors to join us. This new and distinctive approach makes us stand out from most players in the world of healthcare investment and has enabled us to build more than 10 companies over the past 10 years.
We are also involved in early stage companies that have already been created, but always by supporting their development by providing our expertise and network.
We have thus contributed to the financing of more than 40 companies, many of which have become recognized leaders in their respective sectors.
Investment Universe
Biotech / Biofund
From patent to medicine: we identify the most promising scientific breakthroughs and create companies able to turn them into treatments.
Discover →HealthTech / Diagnostics
Digital technology is revolutionising diagnostics and patient care. We invest in technologies that concretely improve patient management.
Discover →Growth / Opportunities
We support mature companies to accelerate their growth and enable them to reach a European scale.
Discover →Key Figures
companies financed
since 2009
companies founded
since 2009
in assets
under management
employees in
companies financed
Our Partners
Kurma has created a solid network of partners to transform the most disruptive scientific discoveries into cutting-edge treatments for patients with severe diseases.
Our Proactive
Impact & Sustainability
Approach
A proactive impact & ethical policy
The raison d'être of Kurma Partners fits perfectly with a proactive impact and ethical policy. Its willingness to respond to unmet medical needs contributes to ensuring the health of all.
ESG Charter & UN PRI
Kurma Partners developed an ESG charter in 2020 and joined the UN PRI in June 2021. A policy of vigilance with strict inclusion or exclusion criteria has been implemented with regard to any subject relating to medical bioethics.
Ethics Charter & best practices
Kurma Partners is committed to developing an Ethics Charter for its portfolio companies. By promoting the best ESG practices, Kurma Partners collects extra-financial data on all portfolio companies.
